Attributable Cost of Adult Respiratory Syncytial Virus Illness Beyond the Acute Phase.

Ahuva AverinMark AtwoodReiko SatoKari YacisinElizabeth BegierKimberly SheaDaniel CurcioLinnea HoudeDerek Weycker

Published in: Open forum infectious diseases (2024)

The cost of RSV-LRTI requiring hospitalization or ambulatory care among US adults is substantial, and the economic impact of RSV-LTRI may extend well beyond the acute phase of illness.

Keyphrases

respiratory syncytial virus
healthcare
blood pressure
palliative care
quality improvement
childhood cancer